nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—CYP2B6—malignant glioma	0.703	1	CbGaD
Domperidone—CYP1A2—Carmustine—malignant glioma	0.119	0.57	CbGbCtD
Domperidone—CYP3A4—Temozolomide—malignant glioma	0.0899	0.431	CbGbCtD
Domperidone—DRD3—telencephalic ventricle—malignant glioma	0.00379	0.286	CbGeAlD
Domperidone—DRD2—telencephalic ventricle—malignant glioma	0.0016	0.121	CbGeAlD
Domperidone—DRD3—central nervous system—malignant glioma	0.000518	0.0391	CbGeAlD
Domperidone—Nefazodone—SLC6A3—malignant glioma	0.000506	0.38	CrCbGaD
Domperidone—Perphenazine—CYP2C18—malignant glioma	0.000474	0.356	CrCbGaD
Domperidone—DRD2—brainstem—malignant glioma	0.000434	0.0328	CbGeAlD
Domperidone—DRD2—retina—malignant glioma	0.000419	0.0316	CbGeAlD
Domperidone—DRD3—brain—malignant glioma	0.000411	0.031	CbGeAlD
Domperidone—DRD2—telencephalon—malignant glioma	0.000385	0.0291	CbGeAlD
Domperidone—KCNH2—telencephalon—malignant glioma	0.00038	0.0286	CbGeAlD
Domperidone—Perphenazine—CYP2B6—malignant glioma	0.000352	0.264	CrCbGaD
Domperidone—ABCB1—blood vessel—malignant glioma	0.000343	0.0259	CbGeAlD
Domperidone—KCNH2—medulla oblongata—malignant glioma	0.000298	0.0225	CbGeAlD
Domperidone—DRD2—midbrain—malignant glioma	0.000277	0.0209	CbGeAlD
Domperidone—KCNH2—midbrain—malignant glioma	0.000273	0.0206	CbGeAlD
Domperidone—KCNH2—spinal cord—malignant glioma	0.000266	0.0201	CbGeAlD
Domperidone—CYP2D6—brainstem—malignant glioma	0.000261	0.0197	CbGeAlD
Domperidone—CYP2D6—telencephalon—malignant glioma	0.000232	0.0175	CbGeAlD
Domperidone—DRD2—central nervous system—malignant glioma	0.000219	0.0165	CbGeAlD
Domperidone—KCNH2—central nervous system—malignant glioma	0.000216	0.0163	CbGeAlD
Domperidone—DRD2—cerebellum—malignant glioma	0.000214	0.0161	CbGeAlD
Domperidone—KCNH2—cerebellum—malignant glioma	0.000211	0.0159	CbGeAlD
Domperidone—ABCB1—embryo—malignant glioma	0.000205	0.0154	CbGeAlD
Domperidone—ABCB1—retina—malignant glioma	0.000181	0.0137	CbGeAlD
Domperidone—CYP2B6—central nervous system—malignant glioma	0.000177	0.0134	CbGeAlD
Domperidone—DRD2—brain—malignant glioma	0.000174	0.0131	CbGeAlD
Domperidone—KCNH2—brain—malignant glioma	0.000171	0.0129	CbGeAlD
Domperidone—ABCB1—telencephalon—malignant glioma	0.000167	0.0126	CbGeAlD
Domperidone—CYP2C8—brain—malignant glioma	0.000157	0.0118	CbGeAlD
Domperidone—CYP2B6—brain—malignant glioma	0.000141	0.0106	CbGeAlD
Domperidone—CYP3A4—central nervous system—malignant glioma	0.000134	0.0101	CbGeAlD
Domperidone—CYP2D6—central nervous system—malignant glioma	0.000132	0.00993	CbGeAlD
Domperidone—ABCB1—medulla oblongata—malignant glioma	0.000131	0.00987	CbGeAlD
Domperidone—CYP2D6—cerebellum—malignant glioma	0.000129	0.0097	CbGeAlD
Domperidone—ABCB1—midbrain—malignant glioma	0.00012	0.00902	CbGeAlD
Domperidone—ABCB1—spinal cord—malignant glioma	0.000117	0.0088	CbGeAlD
Domperidone—CYP2D6—brain—malignant glioma	0.000104	0.00788	CbGeAlD
Domperidone—ABCB1—central nervous system—malignant glioma	9.47e-05	0.00714	CbGeAlD
Domperidone—ABCB1—cerebellum—malignant glioma	9.25e-05	0.00698	CbGeAlD
Domperidone—ABCB1—brain—malignant glioma	7.52e-05	0.00567	CbGeAlD
Domperidone—DRD3—Signaling Pathways—NCOR1—malignant glioma	1.49e-05	0.000204	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—RAF1—malignant glioma	1.47e-05	0.000201	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—IL2—malignant glioma	1.46e-05	0.000198	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—AKT2—malignant glioma	1.45e-05	0.000197	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—PIK3CB—malignant glioma	1.44e-05	0.000196	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PIK3CG—malignant glioma	1.44e-05	0.000196	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PDGFRA—malignant glioma	1.43e-05	0.000195	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTGS1—malignant glioma	1.43e-05	0.000195	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.42e-05	0.000194	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PTPN11—malignant glioma	1.41e-05	0.000192	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NOTCH2—malignant glioma	1.4e-05	0.000191	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—PIK3CD—malignant glioma	1.39e-05	0.00019	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SPP1—malignant glioma	1.39e-05	0.000189	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—IDH1—malignant glioma	1.38e-05	0.000188	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—CXCL8—malignant glioma	1.38e-05	0.000188	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KNG1—malignant glioma	1.37e-05	0.000187	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SPHK1—malignant glioma	1.34e-05	0.000182	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTT1—malignant glioma	1.33e-05	0.000181	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—BCHE—malignant glioma	1.33e-05	0.000181	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL2—malignant glioma	1.32e-05	0.00018	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TERT—malignant glioma	1.32e-05	0.000179	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—AKT2—malignant glioma	1.31e-05	0.000179	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.31e-05	0.000179	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.31e-05	0.000179	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NTRK1—malignant glioma	1.31e-05	0.000178	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.29e-05	0.000176	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PDGFB—malignant glioma	1.28e-05	0.000175	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—FGFR1—malignant glioma	1.28e-05	0.000174	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—CAV1—malignant glioma	1.26e-05	0.000172	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PIK3CD—malignant glioma	1.26e-05	0.000172	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—HIF1A—malignant glioma	1.26e-05	0.000172	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTT1—malignant glioma	1.25e-05	0.000171	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GSTP1—malignant glioma	1.25e-05	0.00017	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTGS1—malignant glioma	1.24e-05	0.00017	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—IDH2—malignant glioma	1.24e-05	0.000169	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.24e-05	0.000169	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.24e-05	0.000168	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.23e-05	0.000168	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GSTP1—malignant glioma	1.22e-05	0.000166	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CAV1—malignant glioma	1.22e-05	0.000166	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MMP3—malignant glioma	1.22e-05	0.000166	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CAT—malignant glioma	1.21e-05	0.000166	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—PIK3CB—malignant glioma	1.21e-05	0.000165	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CDKN2B—malignant glioma	1.21e-05	0.000164	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—KDR—malignant glioma	1.2e-05	0.000164	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CAT—malignant glioma	1.19e-05	0.000162	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTGS1—malignant glioma	1.17e-05	0.00016	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PTK2—malignant glioma	1.17e-05	0.000159	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.17e-05	0.000159	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CXCL8—malignant glioma	1.17e-05	0.000159	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—F2—malignant glioma	1.16e-05	0.000158	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—FN1—malignant glioma	1.16e-05	0.000158	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—BCHE—malignant glioma	1.16e-05	0.000158	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CG—malignant glioma	1.15e-05	0.000157	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HES1—malignant glioma	1.15e-05	0.000157	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—NCOR1—malignant glioma	1.15e-05	0.000156	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—BAD—malignant glioma	1.15e-05	0.000156	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—SLC5A5—malignant glioma	1.14e-05	0.000156	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NCOR1—malignant glioma	1.14e-05	0.000156	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NOTCH1—malignant glioma	1.13e-05	0.000155	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—RAF1—malignant glioma	1.13e-05	0.000154	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.13e-05	0.000153	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—NCOR1—malignant glioma	1.12e-05	0.000153	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—IL2—malignant glioma	1.11e-05	0.000152	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PPARG—malignant glioma	1.11e-05	0.000151	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CD80—malignant glioma	1.11e-05	0.000151	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CG—malignant glioma	1.11e-05	0.000151	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—APC—malignant glioma	1.11e-05	0.000151	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PIK3CB—malignant glioma	1.1e-05	0.00015	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EGF—malignant glioma	1.1e-05	0.000149	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PDGFRA—malignant glioma	1.09e-05	0.000149	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—BCHE—malignant glioma	1.09e-05	0.000149	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PTPN11—malignant glioma	1.09e-05	0.000148	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.09e-05	0.000148	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.08e-05	0.000147	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.07e-05	0.000146	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—IDH1—malignant glioma	1.07e-05	0.000145	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SPP1—malignant glioma	1.06e-05	0.000145	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTT1—malignant glioma	1.06e-05	0.000145	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CXCL8—malignant glioma	1.06e-05	0.000144	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTP1—malignant glioma	1.06e-05	0.000144	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.05e-05	0.000143	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—BRAF—malignant glioma	1.04e-05	0.000142	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SPHK1—malignant glioma	1.03e-05	0.000141	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CAT—malignant glioma	1.03e-05	0.00014	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—AKT2—malignant glioma	1.01e-05	0.000138	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CD—malignant glioma	1.01e-05	0.000138	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.01e-05	0.000138	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL2—malignant glioma	1.01e-05	0.000138	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—EGFR—malignant glioma	1.01e-05	0.000138	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TERT—malignant glioma	1.01e-05	0.000137	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTGS1—malignant glioma	9.94e-06	0.000135	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.9e-06	0.000135	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PDGFB—malignant glioma	9.83e-06	0.000134	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FGFR1—malignant glioma	9.78e-06	0.000133	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CD—malignant glioma	9.75e-06	0.000133	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—NCOR1—malignant glioma	9.71e-06	0.000132	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—PIK3CA—malignant glioma	9.66e-06	0.000132	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HIF1A—malignant glioma	9.63e-06	0.000131	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—KRAS—malignant glioma	9.55e-06	0.00013	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CAV1—malignant glioma	9.35e-06	0.000127	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—FGF2—malignant glioma	9.34e-06	0.000127	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CAV1—malignant glioma	9.32e-06	0.000127	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—BCHE—malignant glioma	9.24e-06	0.000126	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KDR—malignant glioma	9.21e-06	0.000126	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTP1—malignant glioma	9.21e-06	0.000125	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CAV1—malignant glioma	9.14e-06	0.000125	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SLC5A5—malignant glioma	9.13e-06	0.000124	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CAT—malignant glioma	8.96e-06	0.000122	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—F2—malignant glioma	8.87e-06	0.000121	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FN1—malignant glioma	8.87e-06	0.000121	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CB—malignant glioma	8.83e-06	0.00012	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—PIK3CA—malignant glioma	8.77e-06	0.00012	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—BAD—malignant glioma	8.76e-06	0.000119	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTGS2—malignant glioma	8.75e-06	0.000119	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MDM2—malignant glioma	8.74e-06	0.000119	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—RAF1—malignant glioma	8.71e-06	0.000119	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NOTCH1—malignant glioma	8.68e-06	0.000118	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTP1—malignant glioma	8.68e-06	0.000118	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.63e-06	0.000118	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ERBB2—malignant glioma	8.61e-06	0.000117	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.55e-06	0.000117	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CG—malignant glioma	8.52e-06	0.000116	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CD80—malignant glioma	8.5e-06	0.000116	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CB—malignant glioma	8.5e-06	0.000116	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CG—malignant glioma	8.49e-06	0.000116	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—APC—malignant glioma	8.49e-06	0.000116	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—NCOR1—malignant glioma	8.46e-06	0.000115	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CAT—malignant glioma	8.44e-06	0.000115	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EGF—malignant glioma	8.39e-06	0.000114	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PTPN11—malignant glioma	8.34e-06	0.000114	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CG—malignant glioma	8.33e-06	0.000113	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PPARG—malignant glioma	8.22e-06	0.000112	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTT1—malignant glioma	8.18e-06	0.000112	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CXCL8—malignant glioma	8.17e-06	0.000111	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PPARG—malignant glioma	8.04e-06	0.00011	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—BRAF—malignant glioma	7.98e-06	0.000109	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NCOR1—malignant glioma	7.97e-06	0.000109	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CAV1—malignant glioma	7.92e-06	0.000108	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—AKT1—malignant glioma	7.89e-06	0.000108	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CASP3—malignant glioma	7.82e-06	0.000107	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL2—malignant glioma	7.81e-06	0.000106	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AKT2—malignant glioma	7.77e-06	0.000106	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—EGFR—malignant glioma	7.73e-06	0.000105	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTGS1—malignant glioma	7.67e-06	0.000105	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTEN—malignant glioma	7.63e-06	0.000104	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.56e-06	0.000103	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CD—malignant glioma	7.49e-06	0.000102	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CD—malignant glioma	7.46e-06	0.000102	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.46e-06	0.000102	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	7.39e-06	0.000101	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MMP9—malignant glioma	7.39e-06	0.000101	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTP1—malignant glioma	7.35e-06	0.0001	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PTEN—malignant glioma	7.34e-06	0.0001	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CD—malignant glioma	7.32e-06	9.97e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—KRAS—malignant glioma	7.31e-06	9.95e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CG—malignant glioma	7.21e-06	9.83e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—AKT1—malignant glioma	7.16e-06	9.76e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CAT—malignant glioma	7.15e-06	9.75e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FGF2—malignant glioma	7.14e-06	9.73e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—BCHE—malignant glioma	7.13e-06	9.72e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SLC5A5—malignant glioma	7.04e-06	9.6e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PPARG—malignant glioma	6.96e-06	9.48e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CAV1—malignant glioma	6.9e-06	9.4e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NCOR1—malignant glioma	6.76e-06	9.2e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	6.71e-06	9.14e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MDM2—malignant glioma	6.68e-06	9.11e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—RAF1—malignant glioma	6.66e-06	9.08e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—VEGFA—malignant glioma	6.63e-06	9.04e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ERBB2—malignant glioma	6.59e-06	8.98e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—STAT3—malignant glioma	6.57e-06	8.95e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CB—malignant glioma	6.53e-06	8.89e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CB—malignant glioma	6.5e-06	8.86e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CAV1—malignant glioma	6.5e-06	8.86e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTGS2—malignant glioma	6.47e-06	8.81e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CB—malignant glioma	6.38e-06	8.69e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CD—malignant glioma	6.34e-06	8.64e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTGS2—malignant glioma	6.32e-06	8.61e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CG—malignant glioma	6.28e-06	8.56e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CXCL8—malignant glioma	6.25e-06	8.52e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MYC—malignant glioma	6.1e-06	8.32e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PPARG—malignant glioma	6.06e-06	8.26e-05	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—AKT1—malignant glioma	6.04e-06	8.23e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CASP3—malignant glioma	5.98e-06	8.15e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL2—malignant glioma	5.97e-06	8.14e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EGFR—malignant glioma	5.97e-06	8.13e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.92e-06	8.07e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PPARG—malignant glioma	5.71e-06	7.79e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTP1—malignant glioma	5.67e-06	7.73e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MMP9—malignant glioma	5.65e-06	7.7e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTEN—malignant glioma	5.64e-06	7.69e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—KRAS—malignant glioma	5.64e-06	7.68e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PTEN—malignant glioma	5.62e-06	7.66e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CB—malignant glioma	5.53e-06	7.53e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CD—malignant glioma	5.52e-06	7.53e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CAT—malignant glioma	5.52e-06	7.52e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTEN—malignant glioma	5.51e-06	7.51e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CAV1—malignant glioma	5.51e-06	7.5e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—AKT1—malignant glioma	5.48e-06	7.47e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTGS2—malignant glioma	5.48e-06	7.46e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CA—malignant glioma	5.38e-06	7.33e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.26e-06	7.17e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NCOR1—malignant glioma	5.21e-06	7.1e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CD—malignant glioma	5.21e-06	7.09e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CA—malignant glioma	5.18e-06	7.06e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—VEGFA—malignant glioma	5.08e-06	6.92e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—STAT3—malignant glioma	5.03e-06	6.85e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CG—malignant glioma	5.02e-06	6.83e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TP53—malignant glioma	5.01e-06	6.83e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PPARG—malignant glioma	4.84e-06	6.6e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CB—malignant glioma	4.81e-06	6.56e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTEN—malignant glioma	4.78e-06	6.51e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTGS2—malignant glioma	4.77e-06	6.5e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MYC—malignant glioma	4.67e-06	6.36e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EGFR—malignant glioma	4.57e-06	6.22e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.54e-06	6.18e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTGS2—malignant glioma	4.5e-06	6.13e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CD—malignant glioma	4.41e-06	6.01e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—AKT1—malignant glioma	4.4e-06	5.99e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KRAS—malignant glioma	4.32e-06	5.88e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CAV1—malignant glioma	4.25e-06	5.79e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—AKT1—malignant glioma	4.23e-06	5.77e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTEN—malignant glioma	4.16e-06	5.67e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.98e-06	5.42e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CA—malignant glioma	3.96e-06	5.4e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTEN—malignant glioma	3.92e-06	5.34e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CA—malignant glioma	3.89e-06	5.3e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.87e-06	5.27e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.84e-06	5.24e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TP53—malignant glioma	3.84e-06	5.23e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTGS2—malignant glioma	3.81e-06	5.19e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PPARG—malignant glioma	3.74e-06	5.09e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.4e-06	4.64e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CA—malignant glioma	3.37e-06	4.59e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTEN—malignant glioma	3.32e-06	4.53e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—AKT1—malignant glioma	3.25e-06	4.43e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AKT1—malignant glioma	3.24e-06	4.41e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—AKT1—malignant glioma	3.18e-06	4.33e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.97e-06	4.04e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTGS2—malignant glioma	2.94e-06	4e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CA—malignant glioma	2.94e-06	4e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.77e-06	3.77e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—AKT1—malignant glioma	2.75e-06	3.75e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTEN—malignant glioma	2.56e-06	3.49e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—AKT1—malignant glioma	2.4e-06	3.27e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.34e-06	3.19e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—AKT1—malignant glioma	2.26e-06	3.08e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—AKT1—malignant glioma	1.91e-06	2.61e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.81e-06	2.46e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AKT1—malignant glioma	1.48e-06	2.01e-05	CbGpPWpGaD
